Ocugen to apply for full US FDA approval of Covaxin, not for EUA
Ocugen said the decision was based on a recommendation from the US FDA, which also requested more information and data for full…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bharat Biotech
Bharat Biotech facility in Hyderabad gets CISF cover
The registered office and plant of the company located at Genome Valley in the Shameerpet area of Telangana's capital city will be…
Bharat Biotech gets $15 mn upfront from Ocugen for rights to commercialise Covaxin in Canada
Ocugen has agreed to pay another $10 million to Bharat Biotech within a month from the commercial launch of Covaxin in Canada
Anvisa allows import of Covaxin, Sputnik V into Brazil, but conditions apply
According to Anvisa's approval, Brazil is expected to receive four million doses of Covaxin initially
Ocugen, Bharat Biotech sign agreement for commercialisation rights to COVAXIN in Canada
Similar to the US profit share arrangement, Ocugen will retain 45 per cent of the profits from sales of COVAXIN in Canada
IIL to produce drug substance for Covaxin from June
Plans to dispatch the first batch to Bharat Biotech by July
120 days to make, test and release each Covaxin batch: Bharat Biotech
Production scale-up of vaccines is a step-by-step process, involving several regulatory SOPs of GMP. There is a four-month lag…
Bharat Biotech may begin paediatric trials of COVAXIN in June
Bharath Biotech has received permission to carry out paediatric trials of the vaccine and it may commence trials from June 1
Paediatric trials of Covaxin are likely to start from June 1: Dr Raches Ella
Bharat Biotech is ramping up its manufacturing capacity to 700 million doses which are likely to be achieved by the end of this…
Bharat Biotech ramps up COVAXIN production volumes by additional 200 million
Product availability at Ankleshwar to commence from Q4 2021